It's time to pause on U.S. stocks, say Citigroup strategists. They say invest in these places instead.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 97%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

Citigroup has gone lukewarm on U.S. stocks, saying risks of a recession are not going away and megacap growth stocks could be in for a pullback.

If investors can only cram two events into their weary summer brains this week, then consumer prices and the start of second-quarter earnings season should be priorities.

The S&P 500’s SPX estimated second-quarter earnings decline is 7.2%, which if ends up as the actual quarterly fall, will mark the biggest drop since a 31.6% drop seen in the second quarter of 2020, notes John Butters, senior earnings analyst at FactSet. The strategist said Citi’s base case remains an 18 to 19 times [forward price earnings P/E] multiple on full-year earnings. As FactSet’s Butters notes, the current 18.9 times forward 12-month P/E ratio for the S&P 500 is above the 5-year average of 18.6 and the 10-year average of 17.4.

Citi provided this chart, which shows the U.S. sectors they’ve cooled on — tech hardware, household products, food and beverages and healthcare equipment. They turned more positive on capital goods, materials and chips. Japan stocks, which have had a stellar run this year, remain an underweight as they caution that a rush of foreign money into that market could reverse.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Nanobiotix’s stock soars after entering licensing, development deal with J&J’s Janssen PharmaceuticaShares of Nanobiotix SA shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company announced a global...
Source: MarketWatch - 🏆 3. / 97 Read more »

Asian Stock Market: Remains mixed amid sheer fall in China’s PPI, oil correctsMarkets in the Asian domain have shown a decent recovery on Monday despite a sheer slowdown in China’s consumer and Producer Price Index (PPI) and wag
Source: FXStreetNews - 🏆 14. / 72 Read more »